SYNTHESIS AND PHARMACOLOGICAL ACTIVITY OF STEREOISOMERS OF 1,4-DIHYDRO-2,6-DIMETHYL-4-(3-NITROPHENYL)-3,5-PYRIDINEDICARBOXYLIC ACID METHYL 1-(PHENYLMETHYL)-3-PIPERIDINYL ESTER

被引：0

作者：

MUTO, K ^{[1
]}

KURODA, T ^{[1
]}

KAWATO, H ^{[1
]}

KARASAWA, A ^{[1
]}

KUBO, K ^{[1
]}

NAKAMIZO, N ^{[1
]}

机构：

[1] KYOWA HAKKO KOGYO CO,PHARMACEUT RES LABS,1188 SHIMOTOGARI,NAGAIZUMI,SHIZUOKA 411,JAPAN

来源：

ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 1988年 / 38-2卷 / 11A期

关键词：

D O I：

暂无

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：1662 / 1665

页数：4

共 50 条

[1] BIOTRANSFORMATION OF 1,4-DIHYDRO-2,6-DIMETHYL-4-(2-TRIFLUOROMETHYLPHENYL)-3,5-PYRIDINEDICARBOXYLIC ACID DIETHYL ESTER
PARKER, SE
WEINSTOCK, J
JOURNAL OF MEDICINAL CHEMISTRY, 1973, 16 (01) : 34 - 37
[2] METABOLISM OF ANTIHYPERTENSIVE AGENT 1,4-DIHYDRO-2,6-DIMETHYL-4-(2-TRIFLUOROMETHYLPHENYL)-3,5-PYRIDINEDICARBOXYLIC ACID DIETHYL ESTER
WALKENSTEIN, SS
INTOCCIA, AP
FLANAGAN, TL
HWANG, B
FLINT, D
WEINSTOCK, J
VILLANI, AJ
BLACKBURN, D
GREEN, H
JOURNAL OF PHARMACEUTICAL SCIENCES, 1973, 62 (04) : 580 - 584
[3] STRUCTURE OF METHYL 2-(NITROOXY)ETHYL 1,4-DIHYDRO-2,6-DIMETHYL-4-(3-NITROPHENYL)-3,5-PYRIDINEDICARBOXYLATE
OGAWA, T
MATSUMOTO, K
YOKOO, C
HATAYAMA, K
KITAMURA, K
ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1993, 49 : 993 - 996
[4] EMPLOYING IONIZATION BEHAVIORS TO RESOLVE A TRACE-LEVEL IMPURITY - DETERMINATION OF 1,4-DIHYDRO-2,6-DIMETHYL-4-(3-NITROPHENYL)-3,5-PYRIDINEDICARBOXYLIC ACID DI-2-[METHYL-(PHENYLMETHYL)AMINO]ETHYL ESTER IN NICARDIPINE DRUG SUBSTANCE
MAURIN, MB
VICKERY, RD
MA, P
MANALO, J
HUSSAIN, MA
PHARMACEUTICAL RESEARCH, 1992, 9 (11) : 1518 - 1520
[5] SYNTHESIS AND CONFIGURATIONAL ASSIGNMENT OF METHYL 3-NITROOXYPROPYL 1,4-DIHYDRO-2,6-DIMETHYL-4-(3-NITROPHENYL)PYRIDINE-3,5-DICARBOXYLATE
OGAWA, T
MATSUMOTO, K
YOKOO, C
HATAYAMA, K
KITAMURA, K
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1993, (04): : 525 - 528
[6] EFFECTS OF THE NEW DIHYDROPYRIDINE DERIVATIVE 1,4-DIHYDRO-2,6-DIMETHYL-4-(3-NITROPHENYL)-3,5-PYRIDINEDICARBOXYLIC ACID METHYL 6-(5-PHENYL-3-PYRAZOLYLOXY)HEXYL ESTER ON THE CARDIOHEMODYNAMICS AND THE ENERGY-METABOLISM OF ISCHEMIC MYOCARDIUM
IMAI, H
MATSUI, K
OCHI, S
NAKAZAWA, M
NAKAGAWA, Y
IMAI, S
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1987, 37-2 (12): : 1348 - 1352
[7] Neuroprotective effects of a dihydropyridine derivative, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)hexyl ester (CV-159), on rat ischemic brain injury
Miyazaki, H
Tanaka, S
Fujii, Y
Shimizu, K
Nagashima, K
Kamibayashi, M
Uehara, T
Okuma, Y
Nomura, Y
LIFE SCIENCES, 1999, 64 (10) : 869 - 878
[8] SYNTHESIS AND COMPARATIVE PHARMACOLOGICAL STUDIES OF 1,4-DIHYDRO-2,6-DIMETHYL-4-(3-NITROPHENYL)PYRIDINE-3,5-DICARBOXYLATES WITH NON-IDENTICAL ESTER FUNCTIONS
MEYER, H
BOSSERT, F
WEHINGER, E
STOEPEL, K
VATER, W
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1981, 31-1 (03): : 407 - 409
[9] REARRANGEMENTS OF 4-(2-AMINOPHENYL)-1,4-DIHYDRO-2,6-DIMETHYL-3,5-PYRIDINEDICARBOXYLIC ACID DIETHYL ESTER
KIM, DH
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1986, 23 (05) : 1471 - 1474
[10] Dibutyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, diisobutyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate and di-tert-butyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
Rowan, KR
Holt, EM
ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY, 1996, 52 : 2207 - 2212

← 1 2 3 4 5 →